***********************************
Brakke Consulting’s
Animal Health News & Notes for September 6, 2024
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
Transaction Insights Seminar – now virtual
Other News
Boehringer Ingelheim
Comitis Capital
FidoCure
GlobalVetLink
Huvepharma
Kennelmaster Foods
Patterson
PetCo (Austria)
Pharmgate
Saiba Animal Health
Three Dog Brands
VAFO
VetriScience
*********************************************
Southwest Veterinary Symposium – SWVS 2024
JOIN us in Fort Worth!
Fort Worth, Texas – Fort Worth Convention Center
September 22-25, 2022
Register TODAY! Southwest Veterinary Symposium — a partnership of the Arkansas, Louisiana, New Mexico, Oklahoma, and Texas Veterinary Medicine Associations which provides continuing education for veterinary professionals. Join us this September in Fort Worth, Texas, where you can learn about the latest innovations and products while exploring our exhibit hall, network with other veterinary professionals, and choose from more than 400+ hours of quality CE/RACE-approved sessions.
www.swvs.org
**************************************
COMPANY NEWS RELEASES
- Boehringer Ingelheim announced it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. Saiba Animal Health’s technology platform uses a therapeutic vaccine approach, which is designed to create an immune response, targeting chronic diseases such as allergy, inflammation and pain. Financial terms were not disclosed. (company press release)
- The FDA announced the approval of Huvepharma‘s Coxidin 90 (generic monensin Type A medicated article) for use in poultry and quail. (FDA)
- The FDA announced the approval of Pharmgate‘s MGA and Deracin (generic melengestrol acetate Type A medicated article and chlortetracycline Type A medicated article) for use in beef and dairy heifers. (FDA)
- Patterson Veterinary Supply, Inc. announced the addition of pute.us its product offering portfolio. pute.us is a provider of both hardware – including printers, security cameras and phones – and managed concierge IT services for veterinary practices nationwide. (company press release)
- VetriScience announced a rebranding with new logo and the launch of HMB Healthy Muscle & Strength granules for dogs. (company press release)
- The U.S. Patent and Trademark Office has granted FidoCure a patent for a novel targeted therapy and biomarker to treat canine bladder cancer. The company plans to seek FDA approval for the therapy. The AI-driven protocol draws from FidoCure’s proprietary cancer data set — 2 billion data points collected by sequencing and treating thousands of dogs. (Todays Veterinary Business)
- GlobalVetLink announced a breakthrough in Rabies Vaccination Certificate preparation for veterinary clinics. Key Features of GlobalVetLink Rabies Vaccination Certificates include total automation and instant regulatory submission to the appropriate regulatory authorities, among others. (prnewswire)
- Three Dog Brands, a Topspin Consumer Partners portfolio company, announced it has acquired Kennelmaster Foods, a manufacturer and marketer of savory pet treats under the Chip’s Naturals brand. Financial terms were not disclosed. (Pet Product News)
- AUSTRIA VAFO announced it has acquired a majority share of Austrian manufacturer PetCo from German private equity (PE) firm Comitis Capital. Financial terms were not disclosed. (Globalpets)
*****************************************
Brakke Consulting
Transaction Insights: Unlocking the Secrets to Successful Business Deals in Animal Health
Now a three-session virtual event beginning September 25, 2024
Are you seeking to navigate the complex landscape of buying and selling businesses or technology in the animal health and nutrition industry? Given the success of last year’s relaunch, we are excited to announce our educational transaction seminar for 2024, tailored specifically for animal health professionals.
It’s more than just due diligence – we will help you unlock the secrets to successful deals in animal health. This comprehensive seminar is designed to equip you with the knowledge, tools, and strategies to make informed decisions and to successfully manage a transaction in the animal health industry. Presenters include Senior Brakke Consultants Jim Kroman, Paul Casady, and Randy Freides.
The format now is virtual (Zoom) and will be held over three days, September 25, October 2, and October 16. Each session will start at 1 pm ET and last 2 hours, followed by 30 minutes of questions, answers and discussions. Each session will be recorded in case you are unable to attend.
To view the event agenda, click here. To register, click here. Sign up by September 13 to receive our discount price of $1,000. Registration after July 26 will be $1,200. For more information, contact Amanda McDavid at amcdavid@brakkeconsulting.com or 336.396.3916.
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- US – TELEMEDICINE The FDA has published a Q&A page about Federal requirements related to a veterinarian’s role in dispensing prescription animal drugs and to the establishment of a veterinarian-client-patient relationship (VCPR) in the course of practice. The Q&As only cover the veterinarian’s obligations under Federal law; veterinarians should also consult their state licensing boards to determine if there are additional requirements at the state or local level. (FDA)
- US – BOVINE ANAPLASMOSIS Researchers at the University of Missouri have developed a vaccine to protect cattle against anaplasmosis by removing a gene from the Anaplasma marginale The cattle injected with the modified pathogen were successfully immunized against disease. (stlpr.org)
************************************
BRAKKE CONSULTING VIEWPOINT
In last week’s Viewpoint, Jeff Santosuosso recognized the level of innovation as presented by emerging companies at the Kansas City Animal Health Corridor Summit meeting last month. His weekly question then asked what you see as the source of most of the innovation; Corporate R&D, Animal Health Start-ups, Outside our Industry, Universities, or Digital/Data enterprises?
I went back to the program from the KCAH Corridor Summit to see where the technologies disclosed by the 13 selected emerging companies that presented at the Summit would fit on this scale.
I found, as best as I can tell, that the actual sources are:
* Not a surprise, since the big pharma companies seldom seek investment partners and don’t generally disclose research projects prior to launch.
Most of the “Outside our Industry” sources were in-licenses from human health research projects or technologies. It seems we have a healthy mix of sources of innovation as evidenced by the program at the KCAH Corridor Summit. If these 13 companies are an example, our industry pipeline looks promising, with a broad range of offerings to come, and multiple pathways available for good ideas to reach the market.
Jim Kroman
English (United States) 
Portuguese